VanEck Associates’s Cigna CI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.47M | Sell |
24,271
-6,182
| -20% | -$1.71M | ﹤0.01% | 732 |
|
|
2025
Q4 | $8.38M | Buy |
30,453
+10,806
| +55% | +$3.03M | 0.01% | 620 |
|
|
2025
Q3 | $5.66M | Buy |
19,647
+1,427
| +8% | +$422K | 0.01% | 721 |
|
|
2025
Q2 | $6.02M | Sell |
18,220
-376
| -2% | -$121K | 0.01% | 651 |
|
|
2025
Q1 | $6.12M | Buy |
18,596
+3,689
| +25% | +$1.11M | 0.01% | 635 |
|
|
2024
Q4 | $4.12M | Sell |
14,907
-230
| -2% | -$73.3K | 0.01% | 759 |
|
|
2024
Q3 | $4.81M | Buy |
15,137
+265
| +2% | +$91.2K | 0.01% | 658 |
|
|
2024
Q2 | $4.92M | Buy |
14,872
+625
| +4% | +$216K | 0.01% | 585 |
|
|
2024
Q1 | $5.17M | Sell |
14,247
-129
| -0.9% | -$42.5K | 0.01% | 565 |
|
|
2023
Q4 | $4.3M | Buy |
14,376
+108
| +0.8% | +$31.6K | 0.01% | 584 |
|
|
2023
Q3 | $4.08M | Buy |
14,268
+474
| +3% | +$135K | 0.01% | 555 |
|
|
2023
Q2 | $3.87M | Buy |
13,794
+1,018
| +8% | +$265K | 0.01% | 570 |
|
|
2023
Q1 | $3.27M | Sell |
12,776
-1,620
| -11% | -$472K | 0.01% | 588 |
|
|
2022
Q4 | $4.77M | Buy |
14,396
+878
| +6% | +$278K | 0.01% | 477 |
|
|
2022
Q3 | $3.75M | Buy |
13,518
+668
| +5% | +$188K | 0.01% | 497 |
|
|
2022
Q2 | $3.39M | Buy |
12,850
+439
| +4% | +$113K | 0.01% | 552 |
|
|
2022
Q1 | $2.97M | Buy |
12,411
+1,167
| +10% | +$273K | 0.01% | 617 |
|
|
2021
Q4 | $2.58M | Buy |
11,244
+383
| +4% | +$81.4K | 0.01% | 643 |
|
|
2021
Q3 | $2.17M | Buy |
10,861
+1,098
| +11% | +$239K | 0.01% | 657 |
|
|
2021
Q2 | $2.31M | Buy |
9,763
+267
| +3% | +$66.7K | 0.01% | 629 |
|
|
2021
Q1 | $2.3M | Buy |
9,496
+1,409
| +17% | +$314K | 0.01% | 576 |
|
|
2020
Q4 | $1.68M | Sell |
8,087
-3
| -0% | -$588 | ﹤0.01% | 569 |
|
|
2020
Q3 | $1.37M | Sell |
8,090
-10,249
| -56% | -$1.8M | ﹤0.01% | 569 |
|
|
2020
Q2 | $3.44M | Sell |
18,339
-5,855
| -24% | -$1.11M | 0.01% | 386 |
|
|
2020
Q1 | $4.29M | Sell |
24,194
-1,295
| -5% | -$251K | 0.02% | 338 |
|
|
2019
Q4 | $5.21M | Buy |
25,489
+1,482
| +6% | +$272K | 0.02% | 364 |
|
|
2019
Q3 | $3.64M | Buy |
24,007
+337
| +1% | +$54.8K | 0.02% | 388 |
|
|
2019
Q2 | $3.73M | Sell |
23,670
-751
| -3% | -$118K | 0.02% | 379 |
|
|
2019
Q1 | $3.93M | Buy |
24,421
+20,251
| +486% | +$3.7M | 0.02% | 372 |
|
|
2018
Q4 | $792K | Buy |
4,170
+142
| +4% | +$29.6K | ﹤0.01% | 571 |
|
|
2018
Q3 | $839K | Sell |
4,028
-54
| -1% | -$10K | ﹤0.01% | 600 |
|
|
2018
Q2 | $694K | Buy |
+4,082
| New | +$707K | ﹤0.01% | 624 |
|
Other funds holding CI
VCM
VPM
VanEck Associates's CI Position: Q1 2026 in Review
VanEck Associates reduced its Cigna (CI) stake by 20% in Q1 2026, selling an estimated $1.71M and leaving 24,271 shares worth $6.47M. The position accounts for ﹤0.01% of the portfolio, ranked #732.
VanEck Associates first reported a position in CI in Q2 2018 and has held it in 32 quarters since. The position peaked at $8.38M in Q4 2025. 1,655 funds tracked by Wall St. Rank hold CI as of Q1 2026.
- VanEck Associates held 24,271 shares of Cigna worth $6.47M as of Q1 2026.
- VanEck Associates sold 6,182 Cigna shares in Q1 2026, an estimated $1.71M.
- Cigna made up ﹤0.01% of VanEck Associates's portfolio in Q1 2026, its #732 holding.
- VanEck Associates first reported a position in Cigna in Q2 2018 and has held it in 32 quarters since.
- VanEck Associates's Cigna position peaked at $8.38M in Q4 2025.
- 1,655 funds tracked by Wall St. Rank held Cigna as of Q1 2026.
Based on VanEck Associates's 13F filing for Q1 2026, filed 15 May 2026.